Published in Virology on May 01, 1988
Conservation of the secondary structure elements of the 5'-untranslated region of cardio- and aphthovirus RNAs. Nucleic Acids Res (1989) 3.81
Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J Virol (1990) 3.08
Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1989) 2.31
A coding RNA sequence acts as a replication signal in cardioviruses. Proc Natl Acad Sci U S A (1999) 2.22
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev (2004) 1.92
Genomic regions of neurovirulence and attenuation in Theiler murine encephalomyelitis virus. Proc Natl Acad Sci U S A (1990) 1.87
Genetic mapping of the ability of Theiler's virus to persist and demyelinate. J Virol (1990) 1.82
Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1991) 1.79
Phylogenetic analysis of the species Theilovirus: emerging murine and human pathogens. J Virol (2008) 1.65
Polyprotein processing of Theiler's murine encephalomyelitis virus. J Virol (1989) 1.64
The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J Virol (1995) 1.60
Molecular cloning of the complete genome of strain GDVII of Theiler's virus and production of infectious transcripts. J Virol (1989) 1.59
Echovirus 22 is an atypical enterovirus. J Virol (1990) 1.55
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci U S A (1994) 1.52
Conserved tertiary structural elements in the 5' nontranslated region of cardiovirus, aphthovirus and hepatitis A virus RNAs. Nucleic Acids Res (1993) 1.46
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Alteration of amino acid 101 within capsid protein VP-1 changes the pathogenicity of Theiler's murine encephalomyelitis virus. J Exp Med (1989) 1.39
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J Virol (1991) 1.37
A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol (1998) 1.32
Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol (1988) 1.31
A single base deletion in the 5' noncoding region of Theiler's virus attenuates neurovirulence. J Virol (1992) 1.30
Determinants of persistence and demyelination of the DA strain of Theiler's virus are found only in the VP1 gene. J Virol (1991) 1.27
CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol (1998) 1.27
Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol (1996) 1.23
The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J Virol (1997) 1.20
Sialylation of the host receptor may modulate entry of demyelinating persistent Theiler's virus. J Virol (2000) 1.18
L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J Virol (1998) 1.16
Role of sialyloligosaccharide binding in Theiler's virus persistence. J Virol (1997) 1.16
Theiler's murine encephalomyelitis virus subgroup strain-specific infection in a murine macrophage-like cell line. J Virol (1997) 1.14
Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol (1997) 1.14
Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence. J Virol (1992) 1.13
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol (1992) 1.11
A determinant for central nervous system persistence localized in the capsid of Theiler's murine encephalomyelitis virus by using recombinant viruses. J Virol (1998) 1.10
Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol (1994) 1.04
The neurovirulence of the DA and GDVII strains of Theiler's virus correlates with their ability To infect cultured neurons. J Virol (1998) 0.95
L* protein of Theiler's murine encephalomyelitis virus is required for virus growth in a murine macrophage-like cell line. J Virol (2000) 0.95
The neurovirulent GDVII strain of Theiler's virus can replicate in glial cells. J Virol (1995) 0.92
Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelination. Brain Pathol (2007) 0.90
Role of VP2 amino acid 141 in tropism of Theiler's virus within the central nervous system. J Virol (1996) 0.89
The GDVII strain of Theiler's virus spreads via axonal transport. J Virol (1999) 0.88
DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. J Virol (1999) 0.88
Molecular characterization of a nondemyelinating variant of Daniel's strain of Theiler's virus isolated from a persistently infected glioma cell line. J Virol (1998) 0.88
Different strains of Theiler's murine encephalomyelitis virus antagonize different sites in the type I interferon pathway. J Virol (2010) 0.87
An attenuated variant of the GDVII strain of Theiler's virus does not persist and does not infect the white matter of the central nervous system. J Virol (1999) 0.86
Transgenic expression of the 3D polymerase inhibits Theiler's virus infection and demyelination. J Virol (2009) 0.86
Transition from acute to persistent Theiler's virus infection requires active viral replication that drives proinflammatory cytokine expression and chronic demyelinating disease. J Virol (2004) 0.85
Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease. J Virol (1997) 0.84
A spontaneous low-pathogenic variant of Theiler's virus contains an amino acid substitution within the predominant VP1(233-250) T-cell epitope. J Virol (1998) 0.83
Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains. J Virol (1999) 0.83
Different subcellular localization of Theiler's murine encephalomyelitis virus leader proteins of GDVII and DA strains in BHK-21 cells. J Virol (2009) 0.82
Epitope-tagged L* protein of Theiler's murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection. J Virol (2002) 0.81
Leader (L) and L* proteins of Theiler's murine encephalomyelitis virus (TMEV) and their regulation of the virus' biological activities. J Neuroinflammation (2006) 0.77
Analysis of the genomic homologous recombination in Theilovirus based on complete genomes. Virol J (2011) 0.76
Modeling the acute and chronic phases of Theiler murine encephalomyelitis virus infection. J Virol (2013) 0.76
Immunization with structural and non-structural proteins of Theiler's murine encephalomyelitis virus alters demyelinating disease. J Neurovirol (2012) 0.75
Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy. J Neuroimmunol (2017) 0.75
Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science (1972) 11.71
Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys (1973) 7.81
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science (1993) 5.78
Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry (1983) 3.49
Glucose metabolism in Neisseria gonorrhoeae. J Bacteriol (1974) 3.01
Automatic Monitoring of primary amines in preparative column effluents with fluorescamine. Anal Biochem (1975) 2.88
Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1989) 2.31
Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys (1973) 2.23
Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J Biol Chem (1984) 2.17
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation. Oral Oncol (2012) 1.98
Isolation and characterization of the opioid peptides from rat pituitary: beta-lipotropin. Proc Natl Acad Sci U S A (1977) 1.86
Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RT-PCR method. Neurology (2004) 1.83
Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med (1997) 1.83
An about 50,000-dalton protein in adrenal medulla: a common precursor of [Met]- and [Leu]enkephalin. Science (1980) 1.81
Alternative translation initiation site in the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1991) 1.79
Characterization of recombinant human interleukin-2 with micromethods. J Chromatogr (1985) 1.76
Effects of unemployment on mental and physical health. Am J Public Health (1985) 1.71
Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology (2000) 1.67
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer. Ann Oncol (2008) 1.66
Putative enkephalin precursors in bovine adrenal medulla. Biochem Biophys Res Commun (1979) 1.63
Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J Virol (1989) 1.62
DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann Neurol (1984) 1.62
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci U S A (2005) 1.60
The leader peptide of Theiler's murine encephalomyelitis virus is a zinc-binding protein. J Virol (1995) 1.60
The effect of short-term and chronic immunosuppression on Theiler's virus demyelination. J Neuroimmunol (1982) 1.57
Cell-specific proteins regulate viral RNA translation and virus-induced disease. EMBO J (2001) 1.56
Strains from both Theiler's virus subgroups encode a determinant for demyelination. J Virol (1990) 1.53
Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci U S A (1994) 1.52
Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis. Ann Neurol (1989) 1.48
Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia (2013) 1.47
Preparation of oligonucleotide-peptide conjugates. Bioconjug Chem (1992) 1.47
Isolation of the opioid heptapeptide Met-enkephalin [Arg6,Phe7] from bovine adrenal medullary granules and striatum. Proc Natl Acad Sci U S A (1979) 1.47
Isolation and characterization of the opioid peptides from rat pituitary: beta-endorphin. Proc Natl Acad Sci U S A (1977) 1.47
Purification and characterization of a monoclonal T-cell suppressor factor specific for poly(LGlu60LAla30LTyr10). Proc Natl Acad Sci U S A (1982) 1.46
ALFRED: the ALelle FREquency Database. Update. Nucleic Acids Res (2003) 1.46
Virus-induced abortion. Studies of equine herpesvirus 1 (abortion virus) in hamsters. Lab Invest (1975) 1.45
Triggering of New Madrid seismicity by late-Pleistocene erosion. Nature (2010) 1.44
A single amino acid change determines persistence of a chimeric Theiler's virus. J Virol (1994) 1.42
Neutralizing monoclonal antibodies to Theiler's murine encephalomyelitis viruses. J Virol (1985) 1.41
Surgical site infection rates: open versus hand-assisted colorectal resections. Tech Coloproctol (2013) 1.41
Active site of human liver aldehyde dehydrogenase. Biochemistry (1987) 1.40
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40
Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol (1991) 1.40
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1982) 1.37
Two adrenal opioid polypeptides: proposed intermediates in the processing of proenkephalin. Proc Natl Acad Sci U S A (1981) 1.34
Resting state in normal and simian virus 40 transformed Chinese hamster lung cells. Proc Natl Acad Sci U S A (1976) 1.33
Probable precursors of [Leu]enkephalin and [Met]enkephalin in adrenal medulla: peptides of 3-5 kilodaltons. Proc Natl Acad Sci U S A (1980) 1.32
Humane and practical implications of using carbon dioxide mixed with oxygen for anesthesia or euthanasia of rats. Lab Anim Sci (1997) 1.32
A protein critical for a Theiler's virus-induced immune system-mediated demyelinating disease has a cell type-specific antiapoptotic effect and a key role in virus persistence. J Virol (1998) 1.32
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release (2003) 1.31
Trypsin-sensitive neutralization site on VP1 of Theiler's murine encephalomyelitis viruses. J Virol (1988) 1.31
A picornaviral protein synthesized out of frame with the polyprotein plays a key role in a virus-induced immune-mediated demyelinating disease. Nat Med (1995) 1.31
Relationship of Theiler's murine encephalomyelitis viruses to the cardiovirus genus of picornaviruses. Intervirology (1986) 1.30
High-performance liquid chromatography and picomole-level detection of peptides and proteins. Methods Enzymol (1981) 1.30
Amino acid sequence of a human leukocyte interferon. Proc Natl Acad Sci U S A (1981) 1.29
Binding assay for opioid peptides with neuroblastoma x glioma hybrid cells: specificity of the receptor site. Brain Res (1978) 1.29
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains. Nature (1980) 1.28
Antigenic difference between viral strains causing classical and mild types of epidemic hemorrhagic fever with renal syndrome in China. J Infect Dis (1984) 1.25
Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci (1999) 1.24
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer. Br J Cancer (2008) 1.23
Vaginal degeneration following implantation of synthetic mesh with increased stiffness. BJOG (2013) 1.19
High molecular weight opioid-containing proteins in striatum. Proc Natl Acad Sci U S A (1978) 1.18
Resection of gastrinomas. Ann Surg (1983) 1.18
A highly potent 3200-dalton adrenal opioid peptide that contains both a [Met]- and [Leu]enkephalin sequence. Proc Natl Acad Sci U S A (1981) 1.18
Studies on the reaction of fluorescamine with primary amines. Arch Biochem Biophys (1974) 1.17
L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J Virol (1998) 1.16
Deterioration in biomechanical properties of the vagina following implantation of a high-stiffness prolapse mesh. BJOG (2013) 1.16
Patients with amyotrophic lateral sclerosis receiving long-term mechanical ventilation. Advance care planning and outcomes. Chest (1996) 1.16
Marked increases in large enkephalin-containing polypeptides in the rat adrenal gland following denervation. J Neurosci (1981) 1.14
Amino acid analysis of proteins and peptides at the picomole level: the fluorescamine amino acid analyzer. Methods Enzymol (1981) 1.14
Influence of Theiler's murine encephalomyelitis virus 5' untranslated region on translation and neurovirulence. J Virol (1992) 1.13
Localization of a neutralization site of Theiler's murine encephalomyelitis viruses. J Virol (1985) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
Purification to homogeneity of camel pituitary pro-opiocortin, the common precursor of opioid peptides and corticotropin. Proc Natl Acad Sci U S A (1979) 1.12
Fluorometric assay of vasopressin and oxytocin: a general approach to the assay of peptides in tissues. Proc Natl Acad Sci U S A (1976) 1.11
Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes. Neurology (1993) 1.11
Pathogenesis of early and late disease in mice infected with Theiler's virus, using intratypic recombinant GDVII/DA viruses. J Virol (1992) 1.11
Transgene optimization significantly improves SIN vector titers, gp91phox expression and reconstitution of superoxide production in X-CGD cells. Gene Ther (2008) 1.11
Comparative psychophysiological studies of alcoholic and nonalcoholic subjects undergoing experimentally induced ethanol intoxication. Psychosom Med (1966) 1.11
Primary structure of rat thymus prothymosin alpha. Proc Natl Acad Sci U S A (1985) 1.10
Characterization of pro-opiocortin, a precursor to opioid peptides and corticotropin. Proc Natl Acad Sci U S A (1978) 1.10
Studies on the kinetics of reaction and hydrolysis of fluorescamine. Arch Biochem Biophys (1974) 1.10
Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J Neurosci (1997) 1.09
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
Supports for reverse-phase high-performance liquid chromatography of large proteins. Anal Biochem (1980) 1.09
A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity. J Immunol (1999) 1.08
Comparison of agar gel electrophoresis and isoelectric focusing in multiple sclerosis and subacute sclerosing panencephalitis. Ann Neurol (1981) 1.08
Haploinsufficiency of MSX1: a mechanism for selective tooth agenesis. Mol Cell Biol (1998) 1.07
Purification of human fibroblast interferon produced in the absence of serum by Cibacron Blue F3GA-Agarose and high-performance liquid chromatography. Methods Enzymol (1981) 1.06
Regulation of excitatory transmission at hippocampal synapses by calbindin D28k. Proc Natl Acad Sci U S A (1995) 1.06
Opioid hexapeptides and heptapeptides in adrenal medulla and brain possible implications on the biosynthesis of enkephalins. Arch Biochem Biophys (1980) 1.06
Physiological regulation of transgene expression by a lentiviral vector containing the A2UCOE linked to a myeloid promoter. Gene Ther (2011) 1.06
Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26 GeV. Phys Rev Lett (2013) 1.05
An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood (2000) 1.05